<DOC>
	<DOCNO>NCT00681408</DOCNO>
	<brief_summary>Nonalcoholic steatohepatitis ( NASH ) occur 2-3 % US population carry 15-20 % chance progression cirrhosis . It closely associated obesity , hyperlipidemia insulin resistance . Therapy usually include recommendation increase exercise begin weight reduce diet goal variably achieve relative effect conjunction pharmacological intervention well define . Moreover , lifestyle change confound result treatment trial quantify condition test measure body fat . Polyunsaturated fatty acid , especially formulation rich omega-3 , widely accept endorsed medical community beneficial effect hyperlipidemia coronary disease risk reduction . Recent data suggest omega-3 fatty acid ameliorate hepatic steatosis human animal model NASH reduce hepatic fat content . We hypothesize one year course omega-3 fatty acid ( 3gm/day ) produce improvement NASH histological injury independent change weight ( BMI ) degree condition measure lactate threshold . The effect supplement compare placebo group control lifestyle change .</brief_summary>
	<brief_title>Omega 3 Fish Oil Supplements v . Placebo Patients With Non-alcoholic Steatohepatitis ( NASH )</brief_title>
	<detailed_description />
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>1 . NASH NAS ( NASH Activity Score ) &gt; 4 evident biopsy perform within 6 month enrollment . 2 . Age 21 year old . 3 . BMI 25 great . 4 . Ability provide inform consent . 1 . Cirrhosis evident clinically biopsy . 2 . Secondary form NASH see bariatric surgery medication induce medication methotrexate , amiodarone , tamoxifen , corticosteroid . 3 . Current past history diabetes hyperlipidemia require specific drug therapy ( see ) . 4 . Current use weight loss medicine , 'fatburner ' similar agent 5 . Alcohol consumption &gt; 30 g/day , currently 3 consecutive month within 5 year . 6 . Other liver disease ( hepatitis C , B , Wilson 's , autoimmune , ct1antitrypsin hemochromatosis HIV 7 . Pregnancy unwillingness use effective form birth control woman child bear year . 8 . Renal insufficiency ( creatinine &gt; 2 ) , symptomatic coronary , peripheral neurovascular disease , symptomatic heart failure advance respiratory disease require oxygen therapy . 9 . Inability provide inform consent . 10 . Any condition opinion primary investigator would contraindicate patient 's participation .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Steatohepatitis</keyword>
	<keyword>NASH</keyword>
	<keyword>NAFLD</keyword>
	<keyword>omega 3 fatty acid</keyword>
	<keyword>Exercise conditioning</keyword>
</DOC>